Hinge Health, Inc.
HNGEHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Hinge Health, Inc. focuses on Health Information Services services and products. Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. The $7.48B market capitalization puts HNGE squarely in mid-cap range for its industry. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
Market Cap
$7.48B
Beta
—
P/E (TTM)
11.28
P/E (Fwd)
30.32
EPS (TTM)
$8.22
EPS (Fwd)
$3.06
ROE
30.4%
ROA
7.7%
Cash
$389.4M
Total Debt
$5.9M
Free CF
$299.6M
52W Change
64.5%
Annual Financials
Cash vs Debt
Where HNGE stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, HNGE finished 54.06% above its 150-day moving average ($59.62) and 63.20% above its 200-day moving average ($56.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HNGE overbought or oversold?
At the September 3, 2026 close, HNGE's RSI(14) was 58.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $389.4M in cash comfortably exceeding the $5.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $299.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 30.4%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $292.7M (2023) to $587.9M (2025), reflecting a 101% increase over the period.
With cash comfortably exceeding debt, HNGE has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing HNGE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.